- Home
- MRUS vs OR Comparison
MRUS vs OR Comparison
Compare MRUS & OR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- OR
- Stock Information
- Founded
- MRUS 2003
- OR 2014
- Country
- MRUS Netherlands
- OR Canada
- Employees
- MRUS N/A
- OR N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- OR Precious Metals
- Sector
- MRUS Health Care
- OR Basic Materials
- Exchange
- MRUS Nasdaq
- OR Nasdaq
- Market Cap
- MRUS 2.9B
- OR 3.1B
- IPO Year
- MRUS 2016
- OR N/A
- Fundamental
- Price
- MRUS $39.45
- OR $18.69
- Analyst Decision
- MRUS Strong Buy
- OR Strong Buy
- Analyst Count
- MRUS 12
- OR 1
- Target Price
- MRUS $87.92
- OR $22.00
- AVG Volume (30 Days)
- MRUS 706.1K
- OR 493.6K
- Earning Date
- MRUS 02-26-2025
- OR 02-19-2025
- Dividend Yield
- MRUS N/A
- OR 1.03%
- EPS Growth
- MRUS N/A
- OR N/A
- EPS
- MRUS N/A
- OR N/A
- Revenue
- MRUS $35,932,000.00
- OR $183,586,365.00
- Revenue This Year
- MRUS N/A
- OR $5.22
- Revenue Next Year
- MRUS $57.37
- OR $29.91
- P/E Ratio
- MRUS N/A
- OR N/A
- Revenue Growth
- MRUS N/A
- OR 1.62
- 52 Week Low
- MRUS $31.62
- OR $12.77
- 52 Week High
- MRUS $61.61
- OR $21.29
- Technical
- Relative Strength Index (RSI)
- MRUS 38.07
- OR 49.50
- Support Level
- MRUS $38.52
- OR $18.19
- Resistance Level
- MRUS $47.75
- OR $18.97
- Average True Range (ATR)
- MRUS 2.05
- OR 0.42
- MACD
- MRUS -0.17
- OR 0.08
- Stochastic Oscillator
- MRUS 16.83
- OR 55.48
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About OR Osisko Gold Royalties Ltd
Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. The company organizes and manages the business under two operating segments: (i) acquiring and managing precious metals and other royalties, streams and other interests, and (ii) the exploration, evaluation and development of mining projects. Geographically, it generates majority of the income from North America and also generates some portions of income from South America, Australia, Africa and Europe.